Plus Therapeutics Inc (PSTV) — Cash Flow-to-Debt Ratio
Plus Therapeutics Inc (PSTV) has a Cash Flow-to-Debt Ratio of -0.51x as of December 2025, meaning its operating cash flow of $-6.26 Million could theoretically repay -1% of its total liabilities ($12.33 Million) in one year. See free cash flow generation of Plus Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Plus Therapeutics Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Plus Therapeutics Inc across 28 annual periods. Also explore net asset growth rate of Plus Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Plus Therapeutics Inc (1998–2025)
Year-by-year debt coverage analysis for Plus Therapeutics Inc. For market capitalisation and broader financial context, see Plus Therapeutics Inc (PSTV) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.69x | $-20.77 Million | $12.33 Million | ▼ -148.8% |
| 2024 | -0.68x | $-10.55 Million | $15.58 Million | ▲ +32.9% |
| 2023 | -1.01x | $-12.85 Million | $12.74 Million | ▼ -35.5% |
| 2022 | -0.74x | $-12.97 Million | $17.42 Million | ▲ +19.3% |
| 2021 | -0.92x | $-10.28 Million | $11.14 Million | ▲ +0.8% |
| 2020 | -0.93x | $-8.43 Million | $9.07 Million | ▼ -247.3% |
| 2019 | -0.27x | $-5.91 Million | $22.07 Million | ▲ +58.1% |
| 2018 | -0.64x | $-11.97 Million | $18.77 Million | ▲ +34.5% |
| 2017 | -0.97x | $-18.13 Million | $18.61 Million | ▼ -17.8% |
| 2016 | -0.83x | $-19.53 Million | $23.62 Million | ▼ -3.0% |
| 2015 | -0.80x | $-20.47 Million | $25.49 Million | ▼ -17.6% |
| 2014 | -0.68x | $-30.33 Million | $44.42 Million | ▲ +23.1% |
| 2013 | -0.89x | $-34.56 Million | $38.93 Million | ▼ -1.5% |
| 2012 | -0.87x | $-32.19 Million | $36.80 Million | ▼ -3.0% |
| 2011 | -0.85x | $-35.32 Million | $41.59 Million | ▼ -56.6% |
| 2010 | -0.54x | $-23.57 Million | $43.47 Million | ▲ +35.3% |
| 2009 | -0.84x | $-23.81 Million | $28.41 Million | ▲ +16.4% |
| 2008 | -1.00x | $-33.39 Million | $33.33 Million | ▼ -3.2% |
| 2007 | -0.97x | $-30.00 Million | $30.91 Million | ▼ -110.1% |
| 2006 | -0.46x | $-16.48 Million | $35.68 Million | ▼ -1343.1% |
| 2005 | -0.03x | $-1.10 Million | $34.40 Million | ▲ +96.8% |
| 2004 | -1.00x | $-12.57 Million | $12.64 Million | ▼ -81.0% |
| 2003 | -0.55x | $-7.25 Million | $13.18 Million | ▼ -6.4% |
| 2002 | -0.52x | $-6.89 Million | $13.32 Million | ▲ +71.1% |
| 2001 | -1.79x | $-8.32 Million | $4.66 Million | ▼ -75.8% |
| 2000 | -1.02x | $-2.98 Million | $2.93 Million | ▼ -133.3% |
| 1999 | -0.44x | $-5.11 Million | $11.72 Million | ▲ +73.9% |
| 1998 | -1.67x | $-1.52 Million | $912.00K | — |